Smoking is associated with the development of adverse events of biological therapy in patients with Inflammatory Bowel Disease

被引：0
|
作者：
Theodoraki, E. [1 ]
Orfanoudaki, E. [2 ]
Foteinogiannopoulou, K. [2 ]
Koutroubakis, I. [2 ]
机构：
[1] Univ Hosp Heraklion, Dept Gastroenterol, Iraklion, Greece
[2] Univ Hosp Heraklion, Sch Med, Dept Gastroenterol, Iraklion, Greece
来源：
JOURNAL OF CROHNS & COLITIS | 2022年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P505
引用
收藏
页码：I466 / I466
页数：1
相关论文
共 50 条
  • [41] Adverse Events of Thiopurine Therapy in Pediatric Inflammatory Bowel Disease and Correlations with Metabolites: A Cohort Study
    Jasmijn Z. Jagt
    Christine D. Pothof
    Hans J. C. Buiter
    Johan E. van Limbergen
    Michiel P. van Wijk
    Marc A. Benninga
    Nanne K. H. de Boer
    Tim G. J. de Meij
    Digestive Diseases and Sciences, 2022, 67 : 241 - 251
  • [42] Genetic associations with adverse events from anti-tumor necrosis factor therapy in inflammatory bowel disease patients
    Lew, Daniel
    Yoon, Soon Man
    Yan, Xiaofei
    Robbins, Lori
    Haritunians, Talin
    Liu, Zhenqiu
    Li, Dalin
    McGovern, Dermot P. B.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (40) : 7265 - 7273
  • [43] Genetic associations with adverse events from anti-tumor necrosis factor therapy in inflammatory bowel disease patients
    Daniel Lew
    Soon Man Yoon
    Xiaofei Yan
    Lori Robbins
    Talin Haritunians
    Zhenqiu Liu
    Dalin Li
    Dermot PB McGovern
    World Journal of Gastroenterology, 2017, (40) : 7265 - 7273
  • [44] Meaningful Symptoms of Immune Checkpoint Inhibitor Therapy-Related Gastrointestinal Adverse Events in Patients With Inflammatory Bowel Disease
    Inagaki, Yuji
    Azuma, Kouji
    Nakamura, Yukihiro
    Kouno, Shunichi
    Matsuda, Yoshinobu
    Atagi, Shinji
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15) : 1748 - +
  • [45] Is passive smoking in childhood associated with inflammatory bowel disease?
    Morris, DL
    Montgomery, SM
    Pounder, RE
    Wakefield, AJ
    GUT, 2001, 48 : A86 - A86
  • [46] Optimising biological therapy in inflammatory bowel disease patients: the role of a virtual biological clinic
    Rees, J.
    Maher, C.
    Jones, J.
    Slater, J.
    Bates, B.
    Rattehalli, D.
    De Silva, S.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S509 - S509
  • [47] Skin injuries associated with biological therapy in inflammatory bowel disease: beyond psoriasis
    Minguez Sabater, Alejandro
    Martinez Delgado, Sara
    Ladron Abia, Pablo
    Bastida, Guillermo
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2022, 45 (01): : 62 - 63
  • [48] Rate of Adverse Events and Associated Health Care Costs for the Management of Inflammatory Bowel Disease in Germany
    Wilke, Thomas
    Groth, Antje
    Long, Grainne H.
    Tatro, Amanda R.
    Sun, Diana
    CLINICAL THERAPEUTICS, 2020, 42 (01) : 130 - 143
  • [49] Letter: Meta-Analysis: Prevalence of Frailty and Associated Adverse Events in Inflammatory Bowel Disease
    Dai, Cong
    Huang, Yu-Hong
    Jiang, Min
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2025, 61 (04) : 744 - 745
  • [50] The effects of smoking on the development of inflammatory bowel disease.
    Bridger, S
    McGregor, C
    Forgacs, IC
    Bjarnason, I
    Macpherson, AJS
    GASTROENTEROLOGY, 1998, 114 (04) : A943 - A943
12345